Showing 1 - 20 results of 29 for search 'A.L. Bakulev', query time: 0.06s
Refine Results
-
1
Methotrexate: Revisited efficiency and safety of drug administration in psoriasis patients by A. L. Bakulev
Published 2017-08-01
Article -
2
Strategy “treat to target” for patients with psoriasis. Relevant issues to biological therapy persistence by A. L. Bakulev
Published 2017-08-01
Article -
3
-
4
-
5
-
6
Microbial eczema: up-to-date topical treatment with silver sulfathiazole by A. L. Bakulev, S. S. Kravchenya, A. N. Platonova
Published 2017-08-01
Article -
7
Dermatoscopy in the diagnosis of pigmented nevi by A. L. Bakulev, O. M. Konopatskova, Yu. V. Stanchina
Published 2019-10-01
Article -
8
-
9
MODERN CONCEPTS OF FARMACOTHERAPY OF HERPES ZOSTER by A.L. Bakulev, T.I. Spiridonova, A.A. Svistunov
Published 2008-06-01
Article -
10
PSORIASIS AS SYSTEM PATHOLOGY by I.V. Kozlova, Yu.V. Shagova, A.L. Bakulev
Published 2008-03-01
Article -
11
-
12
Optimization of therapy for hepatobiliary disorders in psoriatic patients by I V Kozlova, Yu N Myalina, L P Lipina, A L Bakulev
Published 2017-12-01
Article -
13
A case of localized bullous scleroderma by A. L. Bakulev, E. M. Galkina, A. V. Karakaeva, M. V. Litvinenko
Published 2017-08-01
Article -
14
Endothelial dysfunction and its treatment in psoriasis patients by Yu. M. Shtoda, N. A. Slesarenko, A. L. Bakulev, S. R. Utz, A. N. Platonova
Published 2017-08-01
Article -
15
Psoriasis: clinical and epidemiological features and therapy issues by A. L. Bakulev, T. V. Fitileva, E. А. Novodezerkina, I. Gilloteau, Н. Tian, T. Howe, G. Pietri
Published 2018-08-01
Article -
16
Pain management and stroke prevention in HHV-3-associated infection by O. V. Kolokolov, A. L. Bakulev, A. A. Shuldyakov, N. S. Makarov, I. V. Sitkali, A. M. Kolokolova, S. S. Kravchenya
Published 2019-08-01
Article -
17
-
18
Revisiting the question of psoriasis classification by A. E. Karamova, O. Y. Olisova, A. L. Bakulev, M. M. Kokhan, V. R. Khairutdinov, E. V. Sokolovskiy, M. M. Khobeych
Published 2021-12-01
Article -
19
Efficacy and Safety of BCD-085, a Novel Interleukin-17 Inhibitor. Results of Phase II Clinical Trial in Patients with Moderate-to-Severe Plaque Psoriasis by A. V. Samtsov, V. R. Khairutdinov, A. L. Bakulev, A. A. Kubanov, A. E. Karamova, A. V. Artem’eva, T. V. Korotaeva
Published 2018-01-01
Article -
20